For Research Purposes Only

AOD-9604 vs FOXO4-DRI

Choosing between AOD-9604 and FOXO4-DRI? This comprehensive comparison breaks down everything you need to know about these two peptides, including their mechanisms, benefits, side effects, and which one might be right for you.

AOD-9604 is a Weight Loss peptide while FOXO4-DRI belongs to the Senolytic category. This comparison helps you understand which might be better suited for your specific goals.

AOD-9604

AOD-9604 (Anti-Obesity Drug)

Category

weight-loss

Research Level

Phase 2 Clinical Trials (discontinued)

FDA Status

not-approved

Best For
  • Fat loss
  • Appetite control
  • Metabolic health

FOXO4-DRI

FOXO4-D-Retro-Inverso

Category

senolytic

Research Level

Preclinical

FDA Status

not-approved

Best For
  • Longevity
  • Cellular cleanup
  • Age reversal

Key Differences

  • AOD-9604 targets weight loss while FOXO4-DRI focuses on senolytic
  • AOD-9604 primarily works through appetite regulation and metabolism
  • FOXO4-DRI primarily works through senescent cell clearance

Similarities

  • Both require careful sourcing from reputable vendors
  • Both have limited long-term human safety data
  • Both are popular in the research peptide community

Detailed Comparison

AspectAOD-9604FOXO4-DRI
OverviewA fragment of human growth hormone (amino acids 177-191) marketed specifically for fat burning without affecting blood sugar or causing GH-related side effects. Now banned from compounding by FDA....A promising senolytic peptide being researched for its potential to clear senescent ("zombie") cells to reverse aspects of biological aging. Showed dramatic results in aged mice....
Primary Uses
  • Fat loss
  • Body composition
  • Metabolic support
  • Senescent cell clearance
  • Anti-aging
  • Longevity
Side Effects
  • Injection site reactions
  • Headaches
  • Unknown long-term effects
  • Unknown - only animal data
  • Potential immune effects
MechanismMimics the fat-burning effects of growth hormone without affecting blood sugar or cell proliferation. Stimulates lipolysis (fat breakdown) and inhibit...Disrupts the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis (cell death) specifically in these damaged cells while leaving...

Frequently Asked Questions

Can I stack AOD-9604 and FOXO4-DRI together?

While some researchers do combine AOD-9604 and FOXO4-DRI, there's limited clinical data on their interaction. If considering a stack, start with lower doses and monitor for any adverse effects. Always consult with a healthcare provider before combining peptides.

Which is more effective, AOD-9604 or FOXO4-DRI?

Effectiveness depends on your specific goals. AOD-9604 excels in weight loss, while FOXO4-DRI is better suited for senolytic. Neither is universally "better" - it depends on what you're trying to achieve.

Is AOD-9604 safer than FOXO4-DRI?

Both peptides have different safety profiles and limited long-term human data. AOD-9604 and FOXO4-DRI each carry their own risks and potential side effects. Review the research and consult a healthcare provider to assess which might be more appropriate for your situation.

How do the costs of AOD-9604 and FOXO4-DRI compare?

Pricing varies significantly based on source, purity, and quantity. Generally, both peptides are available at similar price points on the research market, though FDA-approved versions (where applicable) are considerably more expensive.

Verdict

AOD-9604 and FOXO4-DRI serve different purposes - AOD-9604 for weight loss and FOXO4-DRI for senolytic. Rather than choosing one over the other, consider which category aligns better with your current goals. Some researchers use both for complementary benefits.

Disclaimer: This comparison is for educational and research purposes only. Neither peptide is approved for human consumption. Always consult qualified professionals for research guidance.